A B S T R A C T I tested the hypothesis that chronic hyperglycemia alters fetal lung maturation by continuous infusion of glucose (14±2 mg/kg per min, mean±SE) from 112 up to 145 d gestation into six chronically catheterized fetal lambs from which tracheal fluid could be collected. Serum glucose levels (32±2 mg/dl) and serum insulin levels (38±4 ,uU/ml) in these glucose-treated fetuses were significantly higher than serum glucose levels (18±2 mg/dl, P <0.001) and serum insulin levels (12±3 IAU/ml, P < 0.001) in six chronically catheterized control fetuses of the same gestational ages. Glucose infusion to the fetuses did not alter maternal serum glucose (60±3 mg/dl) or serum insulin levels (35±5 MAU/ml). Arterial blood gases (pH 7.34±0.01, Po2 24.3±0.5 mmHg, Pco2 41.5±0.9 mmHg), oxygen saturation (73±2%), hematocrit (31±1%), and tracheal fluid flow (2.4±0.1 ml/g per h) in the glucose-treated fetuses were not significantly different from controls. Among the control fetuses, surface active material (SAM) began to appear in tracheal fluid at 123 d gestation and was present in all six fetuses by 129 d gestation, whereas SAM did not appear at all in tracheal fluid of four of the glucosetreated fetuses, and appeared in two at low levels after 142 d gestation. SAM flux in the glucose-treated fetuses (<1 ug/g per h) was statistically lower than SAM flux in the control fetuses (60±9 pug/kg per h, P < 0.001).
INTRODUCTION
The incidence of respiratory distress syndrome (RDS)' is reported by Robert et al. (1) to be increased almost sixfold in infants of diabetic mothers (IDM), even when suitable corrections are made for gestational age. However, RDS may be less prevalent when maternal diabetes is mild and well controlled (2, 3) . The IDM experiences hyperinsulinemia both in utero and in the postnatal period (4-7), particularly when glucose homeostasis is poor (8) .
Stubbs and Stubbs (9) postulated that hyperinsulinemia may be the common link between maternal diabetes mellitus and RDS. Gross et al. (10) have reported that insulin delays the morphologic maturation of fetal rat lung in organ culture, causing a decrease in the number of lamellar bodies in alveolar type II cells. In addition, Smith et al. (11) have reported that insulin inhibits lecithin synthesis by cultured mixed fetal lung cells in the presence of glucocorticoids. However, Sosenko et al. (12) examined lungs obtained from fetuses of alloxan diabetic rabbit does and found surfactant to be functionally impaired in the presence of normal amounts of phosphatidylcholine. Also, Werthammer et al. (13) have suggested that cholesterol may be present in surfactant of IDM and may inhibit the surface active properties by altering the packing properties of the surface film. Disturbed structural maturation of the lung has also been described by Sosenko et al. (14) in fetuses of alloxan diabetic rabbits. ' Abbreviations used in this paper: IDM, infants of diabetic mothers; RDS, respiratory distress syndrome; SAM, surface active material.
In contrast, Epstein et al. (15) found increased rates of incorporation of choline into phosphatidyicholine in lung slices obtained from premature fetuses of glucose-intolerant rhesus monkeys.
Warburton et al. (16) recently reported that primary hyperinsulinemia reduces surface active material flux in tracheal fluid of fetal lambs. However, the insulintreated lambs in this study became hypoglycemic relative to controls. Hence, the reduction in surface active material flux could not be attributed solely to hyperinsulinemia. Moreover, in the human IDM, hyperglycemia rather than hypoglycemia occurs in utero in response to poor maternal glucose homeostasis, although hypoglycemia commonly occurs postnatally.
Because the role of hyperglycemia in the etiology of RDS among IDM is not fully understood, I sought to test the hypothesis that chronic hyperglycemia reduces the flux of surrace active materials into tracheal fluid by infusing glucose into chronically catheterized fetal lambs from which tracheal fluid could be collected.
METHODS
Gestational age of fetal lambs was determined from the time of mating (Nebeker Farms, Santa Monica, CA). In addition, fetal age was estimated from ossification centers in utero, and by extrapolation of fetal weight and crown-rump measurements at delivery; dating by these methods agreed within 3 d. Arterial blood samples (3.5 ml; -1% of fetal blood volume) were obtained every 48-72 h.
Tracheal fluid was collected daily and stored at -40'C for subsequent analysis. The surface active material (SAM) in each tracheal fluid sample was measured on a surface balance (18) . SAM (19) .
Arterial blood gases were measured using a Corning 175 blood gas analyzer (Corning Medical, Medfield, MA). Arterial blood oxygen saturation was measured using a microoximeter (American Optical Co., Buffalo, NY). Serum samples were separated on these days and stored at -40'C for subsequent analysis. Serum Fig. 1 indicate that serum glucose and insulin levels became elevated following the start of the glucose infusion at 112 d gestation in the glucose-treated fetus. In addition, there were no significant differences in arterial blood pH, Pco2, PO2, oxygen saturation and hematocrit between the glucose-treated and the control fetuses.
The rate of tracheal fluid production in the glucosetreated fetuses were 2.4±0.1 ml/kg per h. The rate of tracheal fluid production in the controls was 2.8±0.1 ml/kg per h (not significantly different).
Fetal (intrauterine) death occurred in five of the six glucose-treated fetuses. Arterial blood gases were normal in each case 48 h or less prior to death. However, since arterial blood gases were not sampled more frequently than every 48 to 72 h, data are not reported subsequent to the last known normal blood gas values. One pair of twins was delivered alive by cesarian section at 143-d gestation.
SAM flux into the tracheal fluid of the fetal lambs is shown in Fig. 2 . SAM began to appear in the tracheal fluid of the control fetuses as 123 d gestation and was present in all six control fetuses by 132 The phospholipids in the tracheal fluid were separated into four major fractions (Table I tol, which were not completely separable by thin-layer chromatography. Before 130 d gestation, the total phospholipid content of the tracheal fluid was similar in the control and glucose-treated fetuses. However, the mixed lecithin content of tracheal fluid from the glucose treated fetuses was only 34% of the content in control (P <0.001). Between <130 and >140d gestation, the mean tracheal fluid total phospholipid content rose fourfold, the mixed lecithin content rose ninefold, and the disaturated phosphatidylcholine content rose fourfold in the control fetuses, whereas little or no increase in these measurements occurred in the glucose-treated fetuses. During the same period of gestation, the phosphatidylglycerol content of tracheal fluid increased fourfold in the control fetuses, whereas phosphatidylglycerol was absent from the tracheal fluid of the glucose-treated fetuses. glucose-treated and control fetuses were not signifi-in six chronically catheterized fetal lambs. Philipps et cantly different.
al. (25) reported a fall in arterial oxygen content with chronic glucose infusion to fetal lambs. In the current DISCUSSION study, arterial oxygen content was not measured. How- Continuous intravenous infusion of glucose produced ever, arterial blood gases, specifically Po2, arterial oxsignificant elevation of serum glucose and insulin levels ygen saturation, and hematocrit were not affected by (25) . At the rates of glucose infusion reported here (14±2 mg/kg per min) no acidosis was noted.
Chronic hyperglycemia with secondary hyperinsulinemia was associated with a significant reduction of SAM flux into tracheal fluid of fetal lambs without affecting the rate of tracheal fluid production. The lungs of the fetal lamb produce fluid that flows from the trachea as early as 94 d gestation (26) . Lung fluid production continues until birth. Mean (27) reported that lamellar inclusion bodies are first visible on electron microscopy of alveolar type II cells in fetal lamb lungs at 113 d gestation. Lamellar inclusion bodies are the most probable storage form of pulmonary surfactant. Hence, in the current study, chronic hyperglycemia with secondary hyperinsulinemia was present from the probable time of inception of SAM synthesis and packaging for secretion.
Warburton et al. (16) have recently reported that primary hyperinsulinemia reduces surface active material flux in tracheal fluid of fetal lambs in the presence of intrauterine hypoglycemia. Taken together with the results of the current study, these data implicate hyperinsulinemia as an etiologic factor in the reduction of SAM flux. However, the relationship between fetal hyperinsulinemia and inhibition of fetal lung maturation is complex. Neufeld et al. (28) found increased concentrations of insulin receptors as well as increased affinity of receptors for the hormone in circulating blood monocytes obtained from infants of gestational diabetic mothers. Neufeld et al. (29) have also demonstrated increased insulin binding in membranes obtained from lungs of fetuses from alloxan diabetic rabbit does. Stubbs and Stubbs (9) suggested a possible biochemical mechanism by which insulin might inhibit surfactant phospholipid synthesis. Activation of pyruvate dehydrogenase by insulin (30) would increase conversion of glucose to acetyl-coenzyme A, thereby decreasing production of intermediary metabolites such as glycerol-S-phosphate and dihydroxyacetone phosphate, which are necessary for the synthesis of complex lipids (31) . The results of the current study indicate that decreased amounts of surface active phospholipids reach the tracheal fluid of fetal lambs subjected to chronic hyperglycemia with secondary hyperinsulinemia. Gross 
